Cloning, expression, and characterization of mouse tissue factor pathway inhibitor (TFPI)

Thrombosis and Haemostasis

Volumn 79, Issue 2, 1998, Pages 306-309

  Chang, Jen Yea ^a   Monroe, Dougald M ^a   Oliver, Julie A ^a   Liles, Darla K ^a   Roberts, Harold R ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 11A; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 9A; COMPLEMENTARY DNA; SIGNAL PEPTIDE; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

AMINO ACID SEQUENCE; ARTICLE; BIOCHEMISTRY; BLOOD CLOTTING; CLONING; DNA LIBRARY; DNA SEQUENCE; GENE EXPRESSION; KIDNEY CELL; MACROPHAGE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCREENING; SEQUENCE HOMOLOGY;

EID: 0031909151     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614983     Document Type: Article

References (19)

1. Girard TJ, Warren LA, Novotny WF, Likert KM, Brown SG. Miletich JP, Broze GJ. Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature 1989; 338: 518-20.
2. Wesselschmidt W, Likert K, Huang Z, MacPhail L, Broze GJ. Structural requirements for tissue factor pathway inhibitor interactions with factor Xa and heparin. Blood Coag Fibrin 1993; 4: 661-9.
3. Enjyoji K-i, Miyata T, Kamikubo Y-i, Kato H. Effect of heparin on the inhibition of factor Xa by tissue factor pathway inhibitor: A segment, Gly212-Phe243, of the third Kunitz domain is a heparin-binding site. Biochemistry 1995; 34: 5725-35.
4. Broze GJ, Warren LA, Novotny WF, Higuchi DA, Girard JJ, Miletich JP. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: Insight into Its possible mechanism of action. Blood 1988; 71: 335-43.
5. Wun T-Z, Kretzmer K, Girard T, Miletich J, Broze JG. Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem kunitz-type inhibitory domains. J Biol Chem 1988; 263: 6001-4.
6. Kamei S, Kamikubo Y-i, Hamuro T, Fujimoto H, Ishihara M, Yonemura H, Miyamoto S, Funatsu A, Enjyoji K-i, Abumiya T, Miyata T, Kato H. Amino acid sequence and inhibitory activity of rhesus monkey tissue factor pathway inhibitor (TFPI): comparison with human TFPI. J Biochem 1994; 115:708-14.
7. Girard T, Gailani D, Broze JG. Complementary DNA sequencing of canine tissue factor pathway inhibitor reveals a unique nanomeric repetitive sequence between the second and third kunitz domains. Biochem J 1994; 303: 923-8.
8. Wesselschmidt R, Girard T, Broze JG. cDNA sequence of rabbit lipoprotein-associated coagulation inhibitor. Nucleic Acids Res 1990; 18: 6440.
9. Enjyoji K-i, Emi M, Mukai T, Kato H. cDNA Cloning and expression of rat tissue factor pathway inhibitor (TFPI). J Biochem 1992; 111: 681 -7.
10. Alabama evidence for a conformational change due to high-affinity calcium binding in the first epidermal growth factor domain. J Biol Chem 1990; 265: 10250-4.
11. Lundblad R. A rapid method for the purification of bovine thrombin and the inhibition of purofied enzyme with phenylmethylsulfonyl fluoride. Biochemistry 1971; 10: 2501-6.
12. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162; 156-9.
13. Amaravadi L, King M. A rapid and efficient, nonradioactive method for screening recombinant DNA libraries. BioTechniques 1994; 16: 98-103.
14. Sanger F, Nicklen SL, Coulson AR. DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA. 1977; 74: 5463-7.
15. Chang J-Y, Stafford DW, Straight DL. The roles of factor VII's structural domains in tissue factor binding. Biochemistry 1995; 34: 12227-32.
16. Pedersen A, Nordfang O, Norris F, Wiberg F, Christensen P, Moeller K, Meidahl-Pedersen J, Beck T, Norris K, Hedner U, Kisiel W. Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions. J Biol Chem 1990; 265: 16786-93.
17. Wesselschmidt R, Likert K, Girard T, Wun T-C, Broze GJ. Tissue factor pathway inhibitor: The carboxy-terminus is required for optimal inhibition of factor Xa. Blood 1992; 79: 2004-10.
18. Sprecher C, Kisiel W, Mathewes S, Foster D. Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor. Proc Natl Acad Sci USA 1994; 91: 3353-7.
19. Broze GJ, Warren L, Novotny W, Roesch K, Miletich J. Properties of the lipoprotein associated coagulation inhibitor produced by HepG2 cells. Blood 1987: 70: 385a.